Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences. British Journal of Cancer (BJC) exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients. BJC works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.Full research papers and short communications are published under five broad headings: * clinical studies * translational therapeutics * molecular diagnostics * genetics and genomics * epidemiologyBJC regularly invites minireviews on topics of current interest from international authorities. Some longer reviews, and book reviews are published, usually by editor's invitation. Editorials and letters to the editor on matters arising from published papers are also published at the editor's discretion.BJC is owned by Cancer Research UK, the world's leading independent charity dedicated to cancer research. Cancer Research UK carries out scientific research to find news ways of preventing, diagnosing and treating cancer; ensuring findings are used to benefit the lives of cancer patients.BJC reflects this purpose. It was founded more than sixty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made British Journal of Cancer one of the world's premier general cancer journals.
From Biology to Clinical practice : a modern approach of oncologyWhile giving space to review articles and paying more attention to biological aspects, the Bulletin du Cancer maintains a highly scientific clinical and therapeutic approach.The Bulletin du Cancer is one of the best scientific publications in the French language in the realm of cancerology. It is listed in the leading international databases.The Bulletin du Cancer is the official organ of the French Cancer Society.The online version of Bulletin du Cancer is available. All articles published since 1997 can now be accessed online. Recent articles are available by pay per view or by subscription while older ones have free access.